The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Clinical trial NCT02432417 · WITHDRAWN

Trial details

NCT number: NCT02432417
Sponsor: Maastricht Radiation Oncology
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Astrocytoma, Grade IV

Start date: 2023-11-10
Primary completion: 2023-11-10
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.